Q-Med trading update for the third quarter of 2009

In order to ensure that shareholders have up to date information, Q-Med has deemed it appropriate to provide an interim trading update for the third quarter of 2009. However, it should be noted that there remains a high degree of uncertainty given the current economic environment. Q-Med’s revenues in July and August 2009 have been lower than in the same period in 2008. If revenue development continues at the same rate for the rest of the quarter, total revenues for the third quarter of 2009 will be approximately 20% lower than the same period in 2008. This has contributed to a lower overall operating profit margin for July and August compared to the same period in 2008. Assuming that the operating profit margin for July and August is maintained for the rest of the quarter, the overall operating profit for the third quarter will be approximately 40 MSEK.

About Us

Q-Med is a rapidly growing and profitable biotechnology and medical device company that develops, produces and markets medical implants. Operations focus on four areas, Esthetics, Orthopedics, Uro-Gynecology, and Cell Therapy and Encapsulation.

Subscribe

Documents & Links